PLDT Inc. Sponsored ADR (PHI)

SG&A Expenses

₱18.42B

Quarterly · Period ending: · PHP

PHI logo

PHI SG&A Expenses

Latest reported₱18.42B PHP
PHI Quarterly SG&A Expenses · PHP (₱0.00 → ₱18.42B)
High-resolution chart · PNG

PHI sg&a expenses history

Quarterly · PHP. Dates are reporting period ends; fiscal years can differ from calendar years.

PLDT Inc. Sponsored ADR SG&A Expenses — Quarterly (PHP)
Period endingSG&A Expenses (PHP)
18,422,000,000
9,286,000,000
22,912,389,000
19,041,000,000
19,121,000,000
9,429,000,000
10,424,000,000
18,990,000,000
20,469,000,000
18,749,000,000
13,370,000,000
19,056,000,000
19,582,000,000
11,922,000,000
11,265,000,000
20,136,000,000
21,647,000,000
15,613,000,000
11,086,000,000
19,536,000,000
19,768,000,000
11,778,000,000
14,605,000,000
16,941,000,000
16,337,000,000
11,335,000,000
11,286,000,000
18,964,000,000
16,172,000,000
10,523,000,000
14,035,000,000
17,758,000,000
17,943,000,000
12,516,000,000
12,342,000,000
12,652,000,000
13,612,000,000
12,289,000,000
11,363,000,000
11,967,000,000
12,106,000,000
11,557,000,000
12,257,000,000
11,928,000,000
13,771,000,000
11,153,000,000
10,813,000,000
12,306,000,000
12,599,000,000
11,439,000,000
13,019,000,000
11,787,000,000
11,269,000,000
11,516,000,000
-428,000,000
15,954,000,000
20,171,000,000
15,198,000,000
4,940,000,000
12,177,000,000
9,943,000,000
9,422,000,000
4,825,000,000
12,135,000,000
11,820,000,000
12,482,000,000
13,337,000,000
11,637,000,000
12,036,000,000
12,171,000,000
11,418,405,550
14,370,125,600
10,862,247,440
11,517,671,080
4,297,557,960
12,170,585,610
11,190,164,580
11,317,153,440
11,245,862,250
11,061,061,050
9,350,760,320
8,642,732,670
8,792,898,650
9,412,819,920
7,450,980,530
8,164,383,480
13,314,607,860
7,640,450,080
6,498,599,560
7,752,809,640
8,636,978,384
9,148,022,819
6,642,995,170
5,975,989,770
9,405,265,919
8,253,386,090
7,629,974,242
6,638,871,628
10,207,921,498
5,609,305,721
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.